We are live on ! Find out more
ELC

Edgar Lomax Company Portfolio holdings

AUM $1.4B
1-Year Est. Return 20.67%
This Fund
S&P 500
This Quarter Est. Return
-1.14%
1 Year Est. Return
+20.67%
3 Year Est. Return
+56.64%
5 Year Est. Return
+81.49%
10 Year Est. Return
+226.33%
AUM
$1.56B
AUM Growth
-$50.9M
Cap. Flow
-$27.5M
Cap. Flow %
-1.77%
Top 10 Hldgs %
40.04%
Holding
61
New
Increased
1
Reduced
55
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
MET icon
MetLife
MET
+$1.97M
2
ALL icon
Allstate
ALL
+$1.44M
3
CSCO icon
Cisco
CSCO
+$1.34M
4
CVS icon
CVS Health
CVS
+$1.32M
5
XOM icon
ExxonMobil
XOM
+$1.2M

Sector Composition

Rank Sector Weight
1 Healthcare 23.85%
2 Financials 18.8%
3 Technology 10.54%
4 Consumer Staples 9.81%
5 Industrials 9.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MET icon
1
MetLife
MET
$62.5B
$86.6M 5.55%
1,402,191
-32,660
-2% -$1.97M
CVS icon
2
CVS Health
CVS
$134B
$78.5M 5.04%
925,550
-15,789
-2% -$1.32M
ALL icon
3
Allstate
ALL
$68.3B
$68.2M 4.38%
535,673
-10,910
-2% -$1.44M
CSCO icon
4
Cisco
CSCO
$448B
$66.7M 4.28%
1,225,508
-23,895
-2% -$1.34M
XOM icon
5
ExxonMobil
XOM
$651B
$62.9M 4.03%
1,068,727
-21,065
-2% -$1.2M
CVX icon
6
Chevron
CVX
$383B
$61M 3.91%
601,102
-11,370
-2% -$1.13M
WBA
7
DELISTED
Walgreens Boots Alliance
WBA
$59.9M 3.84%
1,273,360
-22,995
-2% -$1.11M
GD icon
8
General Dynamics
GD
$103B
$50M 3.21%
255,244
-4,205
-2% -$823K
VZ icon
9
Verizon
VZ
$193B
$47.9M 3.07%
886,051
-8,615
-1% -$477K
EXC icon
10
Exelon
EXC
$46.6B
$42.5M 2.73%
1,232,458
-25,292
-2% -$864K
MRK icon
11
Merck
MRK
$321B
$42.4M 2.72%
563,895
-5,635
-1% -$429K
KO icon
12
Coca-Cola
KO
$381B
$42.1M 2.7%
802,522
-15,360
-2% -$856K
UNH icon
13
UnitedHealth
UNH
$383B
$39.4M 2.52%
100,718
-2,132
-2% -$883K
T icon
14
AT&T
T
$159B
$36.6M 2.35%
1,792,566
-21,045
-1% -$442K
JNJ icon
15
Johnson & Johnson
JNJ
$617B
$36.1M 2.32%
223,620
-2,205
-1% -$376K
IBM icon
16
IBM
IBM
$209B
$35.7M 2.29%
269,049
-5,392
-2% -$721K
UNP icon
17
Union Pacific
UNP
$172B
$34M 2.18%
173,320
-2,730
-2% -$590K
PFE icon
18
Pfizer
PFE
$142B
$33.3M 2.13%
773,080
-15,460
-2% -$685K
MMM icon
19
3M
MMM
$90.8B
$32.6M 2.09%
222,085
-4,162
-2% -$674K
PG icon
20
Procter & Gamble
PG
$335B
$30.7M 1.97%
219,570
-2,105
-0.9% -$298K
GS icon
21
Goldman Sachs
GS
$302B
$30.6M 1.96%
80,878
-1,550
-2% -$605K
ABBV icon
22
AbbVie
ABBV
$455B
$30.2M 1.94%
280,128
-3,530
-1% -$403K
AMGN icon
23
Amgen
AMGN
$209B
$30M 1.92%
140,920
-1,375
-1% -$316K
WMT icon
24
Walmart Inc
WMT
$884B
$29.5M 1.89%
635,730
-6,390
-1% -$308K
ORCL icon
25
Oracle
ORCL
$367B
$28.8M 1.84%
330,010
-6,555
-2% -$579K

Similar funds

Edgar Lomax Company's Q3 2021 Portfolio in Review

As of Q3 2021, Edgar Lomax Company held 61 positions worth $1.56B, down 3.2% from $1.61B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 0%. Edgar Lomax Company opened no new positions and made no exits, leaving the 61-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Financials and Technology.

  • Edgar Lomax Company's biggest Q3 2021 reduction was MetLife, cutting an estimated $1.97M.
  • Edgar Lomax Company's ten largest holdings make up 40% of its $1.56B portfolio in Q3 2021.
  • Edgar Lomax Company opened 0 new positions and closed 0 in Q3 2021.
  • Edgar Lomax Company's portfolio value fell 3.2% quarter-over-quarter to $1.56B.

Based on Edgar Lomax Company's 13F filing for Q3 2021, filed 12 Nov 2021.